Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine

Soy, 2007, Cutaneous findings in patients with primary Sjogren's syndrome, Clin Rheumatol, 26, 1350, 10.1007/s10067-006-0374-3

Roguedas, 2004, Cutaneous manifestations of primary Sjogren's syndrome are underestimated, Clin Exp Rheumatol, 22, 632

Alexander, 1983, Cutaneous manifestations of primary Sjogren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies, J Invest Dermatol, 80, 386, 10.1111/1523-1747.ep12552002

Rashtak, 2008, Skin involvement in systemic autoimmune diseases, Curr Dir Autoimmun, 10, 344, 10.1159/000131754

Brito-Zeron, 2014, Annular erythema in primary Sjogren's syndrome: description of 43 non-Asian cases, Lupus, 23, 166, 10.1177/0961203313515764

Ramos-Casals, 2004, Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients, Medicine, 83, 96, 10.1097/01.md.0000119465.24818.98

Scofield, 2011, Vasculitis in Sjogren's Syndrome, Curr Rheumatol Rep, 13, 482, 10.1007/s11926-011-0207-5

Nezos, 2015, Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis, J Autoimmun, 63, 47, 10.1016/j.jaut.2015.07.002

Kuznik, 2011, Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines, J Immunol, 186, 4794, 10.4049/jimmunol.1000702

An, 2017, Antimalarial drugs as immune modulators: new mechanisms for old drugs, Annu Rev Med, 68, 317, 10.1146/annurev-med-043015-123453

1991, A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus, N Engl J Med, 324, 150, 10.1056/NEJM199101173240303

Gottenberg, 2014, Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial, JAMA, 312, 249, 10.1001/jama.2014.7682

Kibune, 2017, Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus, J Dermatol, 44, e52, 10.1111/1346-8138.13560